BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27919626)

  • 1. Targeted delivery of glucocorticoids to macrophages in a mouse model of multiple sclerosis using inorganic-organic hybrid nanoparticles.
    Montes-Cobos E; Ring S; Fischer HJ; Heck J; Strauß J; Schwaninger M; Reichardt SD; Feldmann C; Lühder F; Reichardt HM
    J Control Release; 2017 Jan; 245():157-169. PubMed ID: 27919626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Fluorescent Hybrid Nanoparticles for Traceable Delivery of Glucocorticoids to Inflammatory Sites.
    Napp J; Markus MA; Heck JG; Dullin C; Möbius W; Gorpas D; Feldmann C; Alves F
    Theranostics; 2018; 8(22):6367-6383. PubMed ID: 30613305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly selective organ distribution and cellular uptake of inorganic-organic hybrid nanoparticles customized for the targeted delivery of glucocorticoids.
    Kaiser TK; Khorenko M; Moussavi A; Engelke M; Boretius S; Feldmann C; Reichardt HM
    J Control Release; 2020 Mar; 319():360-370. PubMed ID: 31923534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal encapsulation of glucocorticoids alters their mode of action in the treatment of experimental autoimmune encephalomyelitis.
    Schweingruber N; Haine A; Tiede K; Karabinskaya A; van den Brandt J; Wüst S; Metselaar JM; Gold R; Tuckermann JP; Reichardt HM; Lühder F
    J Immunol; 2011 Oct; 187(8):4310-8. PubMed ID: 21918186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids delivered by inorganic-organic hybrid nanoparticles mitigate acute graft-versus-host disease and sustain graft-versus-leukemia activity.
    Kaiser TK; Li H; Roßmann L; Reichardt SD; Bohnenberger H; Feldmann C; Reichardt HM
    Eur J Immunol; 2020 Aug; 50(8):1220-1233. PubMed ID: 32133644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic development of glucocorticoid resistance during autoimmune neuroinflammation.
    Gold SM; Sasidhar MV; Lagishetty V; Spence RD; Umeda E; Ziehn MO; Krieger T; Schulz KH; Heesen C; Hewison M; Voskuhl RR
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1402-10. PubMed ID: 22659246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine-mediated redirection of T cells constitutes a critical mechanism of glucocorticoid therapy in autoimmune CNS responses.
    Schweingruber N; Fischer HJ; Fischer L; van den Brandt J; Karabinskaya A; Labi V; Villunger A; Kretzschmar B; Huppke P; Simons M; Tuckermann JP; Flügel A; Lühder F; Reichardt HM
    Acta Neuropathol; 2014 May; 127(5):713-29. PubMed ID: 24488308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis.
    Hoepner R; Bagnoud M; Pistor M; Salmen A; Briner M; Synn H; Schrewe L; Guse K; Ahmadi F; Demir S; Laverick L; Gresle M; Worley P; Reichardt HM; Butzkueven H; Gold R; Metz I; Lühder F; Chan A
    Acta Neuropathol; 2019 Sep; 138(3):443-456. PubMed ID: 31030237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis.
    Schmidt J; Metselaar JM; Wauben MH; Toyka KV; Storm G; Gold R
    Brain; 2003 Aug; 126(Pt 8):1895-904. PubMed ID: 12805101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Reichardt HM; Gold R; Lühder F
    Expert Rev Neurother; 2006 Nov; 6(11):1657-70. PubMed ID: 17144780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional phosphate-based inorganic-organic hybrid nanoparticles.
    Heck JG; Napp J; Simonato S; Möllmer J; Lange M; Reichardt HM; Staudt R; Alves F; Feldmann C
    J Am Chem Soc; 2015 Jun; 137(23):7329-36. PubMed ID: 26018463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Fischer HJ; Schweingruber N; Lühder F; Reichardt HM
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):99-107. PubMed ID: 23578583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled delivery of a metabolic modulator promotes regulatory T cells and restrains autoimmunity.
    Gammon JM; Tostanoski LH; Adapa AR; Chiu YC; Jewell CM
    J Control Release; 2015 Jul; 210():169-78. PubMed ID: 26002150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid Nanoparticles Show Full Therapeutic Efficacy in a Mouse Model of Acute Lung Injury and Concomitantly Reduce Adverse Effects.
    Albers GJ; Amouret A; Ciupka K; Montes-Cobos E; Feldmann C; Reichardt HM
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative analysis of multiple sclerosis-relevant anti-inflammatory properties of ethyl pyruvate and dimethyl fumarate.
    Miljković D; Blaževski J; Petković F; Djedović N; Momčilović M; Stanisavljević S; Jevtić B; Mostarica Stojković M; Spasojević I
    J Immunol; 2015 Mar; 194(6):2493-503. PubMed ID: 25681336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages and liposomes in inflammatory disease: friends or foes?
    Crielaard BJ; Lammers T; Morgan ME; Chaabane L; Carboni S; Greco B; Zaratin P; Kraneveld AD; Storm G
    Int J Pharm; 2011 Sep; 416(2):499-506. PubMed ID: 21238559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional concepts and future avenues of glucocorticoid action in experimental autoimmune encephalomyelitis and multiple sclerosis therapy.
    Lühder F; Reichardt HM
    Crit Rev Immunol; 2009; 29(3):255-73. PubMed ID: 19538138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis.
    Xiao J; Liu W; Chen Y; Deng W
    J Neuroinflammation; 2015 Jun; 12():117. PubMed ID: 26068104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
    Craner MJ; Damarjian TG; Liu S; Hains BC; Lo AC; Black JA; Newcombe J; Cuzner ML; Waxman SG
    Glia; 2005 Jan; 49(2):220-9. PubMed ID: 15390090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of glucocorticoids in the control of neuroinflammation.
    Schweingruber N; Reichardt SD; Lühder F; Reichardt HM
    J Neuroendocrinol; 2012 Jan; 24(1):174-82. PubMed ID: 21615563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.